Unilever Ventures Invests in Nutrafol

Unilever Ventures, the venture-capital and private-equity arm of consumer packaged goods conglomerate, has emerged as lead investor at the conclusion of series A financing round for Nutrafol®. Investment platform CircleUp made an initial introduction to the brand. With continued investment in research and clinical studies, Nutrafol says it is poised to take the lead in the fragmented multibillion dollar global hair loss industry.

“Up until now,physicians have had very few, if any, healthy options to offer patients concerned with poor hair health,” says Nutrafol’s president, Roland Peralta. “Our researchers created an award-winning solution that fills the void by providing the medical community a healthy and effective option, without side effects, for their patients in the treatment of poor hair health.”

“Hair loss is a global issue affecting millions of men and women every day. The founding team at Nutrafol, a nutraceutical supplement, has done a phenomenal job disrupting the status quo of the hair loss industry by shifting the paradigm in how western medicine talks about hair loss,” says Stephen Willson, Investment Director, Unilever Ventures. “Consumers are demanding natural solutions that work- the high trajectory growth of the brand is indicative that Nutrafol is on the frontier of that.”

Investment from Unilever Ventures, along with other strategic partners, will be used by Nutrafol to progress scientific research, product development and drive growth in the medical, salon and e-commerce channels, the company says.